Interventional Oncology Devices | Market Insights | Europe (Supplemental) | 2023
Despite the short-term challenges posed by the COVID-19 pandemic, the European market for interventional oncology devices will grow moderately through 2031. This will be driven largely by the expanding treatable patient populations, improved reimbursement, an increasing shift towards higher-priced technologies, and growing physician acceptance of interventional oncology procedures. However, growth in this market will be hindered by mixed clinical data, increasing-price competition, and ongoing cost constraints in the region which has led to a tempered adoption of interventional oncology devices.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for interventional oncology devices in Europe from 2019–2031.
